Table 4. Showing χ2 test done to assess difference with patient sex overall and with stratification of age categories and specific risk factors
Observed (%) having a BHAExpected (%) having a BHAχ2 (P value)
Overall
 Male349 (5.5%)474 (7.5%)59.88 (P = 1 x 10–14)
 Female823 (8.9%)698 (7.5%)
Stratified by age group
Age category (50–74 years) (n = 7975)
 Male205 (5.9%)256.1 (7.4%)19.45 (P = 1 x 10–5)
 Female384 (8.5%)332.9 (7.4%)
Age category (≥75 years) (n = 7606)
 Male144 (5.1%)217.3 (7.7%)42.69 (P = 6 x 10–11)
 Female439 (9.2%)365.7 (7.7%)
Stratified by risk factor
Fractures (n = 1198)
 Male75 (28%)72.5 (27.1%)0.16 (P = 0.69)
 Female249 (26.8%)251.5 (27%)
Falls (n = 9377)
 Male52 (1.3%)83.7 (2%)21.86 (P = 3 × 10–6)
 Female139 (2.6%)107.3 (2%)
Steroids (n = 2677)
 Male124 (10.4%)139.3 (11.7%)3.43 (P = 0.06)
 Female188 (12.7%)172.7 (11.7%)
Two or more risk factors (n = 2329)
 Male98 (13.5%)107.8 (14.8%)1.53 (P = 0.22)
 Female247 (15.4%)237.2 (14.8%)
  • Observed = actual results. Expected = number of patients who would fall in each category if no association between the variables exists. BHA = bone health assessment.